Abstract Details

Title Dose-Dependent Neuroprotection of Acute Interferon-[beta]1a after Spinal Cord Injury in Rat

Topic Critical Care/Emergency Neurology/Trauma

Presentation(s) (-)

Poster/Presentation
Number 167

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
Samuel J. Maiser, MD (Hennepin Healthcare)	Dr. Maiser has nothing to disclose.
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Gabriel Persi (Sanatorio de la Trinidad Mitre)	Gabriel Persi has nothing to disclose.
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file
Darren P. Baker, PhD (Sanofi Genzyme)	Dr. Baker has received personal compensation for serving as an employee of Sanofi. Dr. Baker has received stock or an ownership interest from Sanofi.
	No disclosure on file
Carolyn Winter-Rosenberg	No disclosure on file
Katherine Esse, MD	No disclosure on file
	No disclosure on file
Ezgi Tiryaki, MD, FAAN	Dr. Tiryaki has or had stock in HITIT Leadership Coaching.Dr. Tiryaki has a non-compensated relationship as a Professor of Neurology with University of Minnesota that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Clinic Director of a Center of Excellence with The ALS Association that is relevant to AAN interests or activities. Dr. Tiryaki has a non-compensated relationship as a Volunteer Clinical Neurologist at ALS Clinic with Minneapolis VA Healthcare System that is relevant to AAN interests or activities.
	No disclosure on file

��ɫ����